• Optimizing hiPSC-Derived Platelet Production via Small Molec

  2026-05-15

  This study introduces a robust, cost-efficient protocol for generating functional platelets from human induced pluripotent stem cells (hiPSCs) through targeted use of small molecules and medium refinement. The approach significantly shortens differentiation time, improves yield, and reduces costs, offering important advances for cell therapy applications and scalable platelet manufacturing.

• 2'3'-cGAMP (sodium salt): Precision Tool for STING Pathway R

  2026-05-14

  2'3'-cGAMP (sodium salt) from APExBIO empowers researchers to dissect the STING-mediated innate immune response with unmatched precision and reproducibility. Its high water solubility and superior affinity make it the go-to tool for advanced immunotherapy, antiviral studies, and robust type I interferon induction workflows.

• Clozapine as a Neuropharmacology Probe: Pathways, Protocols,

  2026-05-14

  Explore Clozapine, a cornerstone atypical antipsychotic medication, as a precision neuropharmacology tool. This article uncovers advanced mechanistic insights, protocol optimization, and practical guidance for schizophrenia research not found in conventional reviews.

• Danazol in Translational Research: Mechanisms and Innovation

  2026-05-13

  This thought-leadership article explores Danazol’s multifaceted role as a research tool in steroidogenesis and androgen signaling. Integrating mechanistic insights, recent animal model discoveries, and strategic guidance, the piece guides translational researchers in optimizing Danazol-based workflows for endocrine and oncology studies, while advocating rigorous, future-focused protocol design.

• Optimizing Protein Extraction with Protease and Phosphatase

  2026-05-13

  Maximize protein integrity and phosphorylation fidelity in complex biological samples using the Protease and Phosphatase Inhibitor Cocktail (EDTA Free, 100X in ddH2O). This guide translates cutting-edge research and practical protocols into actionable workflows, troubleshooting, and assay enhancements for sensitive proteomics and cell signaling studies.

• Cy7 NHS Ester: Hydrophilic Near-Infrared Dye for Bioimaging

  2026-05-12

  Cy7 NHS ester provides a highly water-soluble, sulfonated near-infrared dye for protein and peptide labeling, enabling efficient conjugation without the need for organic co-solvents. It is best suited for in vitro and in vivo imaging workflows requiring minimal fluorescence quenching and compatibility with delicate biomolecules. Use is limited to labeling applications where amino groups are accessible and long-term solution stability is not required.

• Targeting Cathepsin B: Next-Gen Tools for Necroptosis Resear

  2026-05-12

  This thought-leadership article explores the mechanistic and translational significance of cathepsin B inhibition in regulated cell death, highlighting the role of CA-074 Me from APExBIO as a precision tool for dissecting necroptosis and lysosomal pathways. By contextualizing recent findings on MLKL-driven lysosomal membrane permeabilization and systematically guiding translational researchers through experimental and workflow considerations, the article bridges foundational mechanisms with actionable insights for apoptosis, inflammation, and TNF-α-induced liver injury models.

• Probenecid: Applied Workflows for Multidrug Resistance and N

  2026-05-11

  Probenecid (4-(dipropylsulfamoyl)benzoic acid) is more than a transporter inhibitor—it’s a workflow transformer for multidrug resistance, transporter assays, and neuroprotection models. This article delivers actionable experimental strategies, troubleshooting insights, and cross-domain protocol enhancements that leverage APExBIO’s validated Probenecid for reproducible, translational bench science.

• p-Cresyl sulfate: Mechanistic Driver in Endothelial Dysfunct

  2026-05-11

  p-Cresyl sulfate is a protein-bound uremic toxin and biomarker for uremia-related cardiovascular risk. It impairs endothelial cell proliferation, enhances vascular calcification, and is a critical tool for modeling endothelial dysfunction and uremic toxin clearance. High-purity p-Cresyl sulfate from APExBIO enables reproducible translational research.

• Risedronate Sodium: Mechanisms and Modernization in Translat

  2026-05-10

  Explore how Risedronate Sodium, a leading FPP synthase inhibitor, is reshaping the translational landscape in bone and pulmonary research. This article integrates mechanistic insights, protocol benchmarks, and strategic guidance for researchers, advancing beyond conventional product narratives and engaging with cutting-edge evidence, including comparative oncology perspectives.

• Genotyping Kit for Target Alleles: Streamlined DNA Prep & An

  2026-05-09

  Accelerate molecular genotyping across insects, tissues, fishes, and cells with a single-tube solution that eliminates phenol extraction and reduces contamination risk. This workflow-focused article details applied use-cases, advanced troubleshooting, and protocol optimization for the Genotyping Kit for target alleles.

• I-BET151 (GSK1210151A): Technical Guide for BET Inhibition A

  2026-05-08

  I-BET151 (GSK1210151A) is a selective BET bromodomain inhibitor optimized for modulating BRD2, BRD3, and BRD4 activity in cancer biology research, especially in apoptosis and cell cycle arrest assays. It is recommended for preclinical workflows and mechanistic studies, but is not suitable for diagnostic or clinical use. Proper handling, solubilization, and workflow design are essential to ensure robust and reproducible results.

• Jiedu Xiaozheng Yin Induces M1 Macrophage Polarization via T

  2026-05-08

  Liu et al. (2024) demonstrate that Jiedu Xiaozheng Yin (JXY), a traditional Chinese medicine compound, suppresses colitis-associated colorectal cancer (CAC) progression by promoting macrophage polarization toward the pro-inflammatory M1 phenotype through the TLR4 pathway. This mechanistic insight highlights the therapeutic promise of modulating innate immune responses in CAC and provides a foundation for integrating transcription factor inhibitors in cancer immunomodulation research.

• Tumor-Targeted PAD4 Inhibition via PBA: Mechanistic Advances

  2026-05-07

  This study introduces phenylboronic acid (PBA)-modified PAD4 inhibitors that selectively target tumor and neutrophil PAD4 activity, suppressing tumor growth and metastasis by blocking the PAD4-H3cit-NETs pathway. The work offers a mechanistic rationale for highly specific antitumor intervention with reduced off-target toxicity.

• Hepatic Cellular Interactions of PEGylated Iron Oxide Nanopa

  2026-05-07

  This study systematically dissects how nanoparticle size and PEGylation determine the fate of iron oxide nanoparticles in the liver. The findings revise established models by showing that hepatocytes and stellate cells, not Kupffer cells, are the primary mediators of hepatic nanoparticle uptake, guiding future nanomedicine design for improved targeting.

16331 records 1/1089 page Next 12345 下5页 Last page